| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |